Physician
Maciborski, Melissa
Maciborski, Melissa was paid $147K by Medicaid between Jan 2018 and Mar 2023, across 18 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 36% of everything it billed.
33Billing provider infoMACIBORSKI, MELISSA
HUTTO, TX 78634
HUTTO, TX 78634
33aNPI1982808556assigned 06/14/2007
33bProvider typePediatrics Physician
28Total paid$147K
24GClaims3,957
24DCodes billed18
24AFirst – last monthJan 2018 – Mar 2023
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#674 of 1,136
Median peer was paid$329K
This provider vs. median0.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 369 | $20K | |
| 2019 | 236 | $13K | |
| 2020 | 60 | $4K | |
| 2021 | 40 | $2K | |
| 2022 | 2,374 | $78K | |
| 2023 | 878 | $30K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 496 | 481 | $52K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 653 | 630 | $40K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 10% | 297 | 288 | $15K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 6.7% | 248 | 248 | $10K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4.3% | 271 | 263 | $6K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.1% | 57 | 57 | $5K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 2.9% | 475 | 473 | $4K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.6% | 294 | 290 | $4K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.4% | 24 | 24 | $2K |
| 94760 | 1.2% | 894 | 856 | $2K | |
| 96127 | <1% | 104 | 103 | $1K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 14 | 14 | $1K |
6 more codes
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 12 | $1K |
| 90461 | <1% | 28 | $934.80 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 27 | $835.65 |
| 99173 | <1% | 29 | $644.38 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 21 | $429.45 |
| 99188 | <1% | 13 | $338.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.